ADA and immunodeficiency disease: The survival profiles of the immunodeficiencies were significantly different (p = 0.0141) and ranged, at 5 years, from 100% for ADA-SCID to 78.8% (95% CI = 61.2–100%) for X-CGD (Supplementary Fig. 1D).